Schweiz - Deutsch - Swissmedic (Swiss Agency for Therapeutic Products)

roche pharma (schweiz) ag - emicizumabum - injektionslösung - emicizumabum 105 mg, histidinum, acidum asparticum ad ph, argininum, poloxamerum 188, aqua ad iniectabile ad solutionem pro 0.7 ml. - hämophilie a - biotechnologika

Schweiz - Deutsch - Swissmedic (Swiss Agency for Therapeutic Products)

roche pharma (schweiz) ag - emicizumabum - injektionslösung - emicizumabum 150 mg, histidinum, acidum asparticum ad ph, argininum, poloxamerum 188, aqua ad iniectabile ad solutionem pro 1 ml. - hämophilie a - biotechnologika

Schweiz - Deutsch - Swissmedic (Swiss Agency for Therapeutic Products)

b. braun medical ag - isoleucinum, leucinum, lysinum anhydricum, methioninum, phenylalaninum, threoninum, tryptophanum, valinum, argininum, histidinum, alaninum, glycinum, säure asparticum, säure glutamicum, prolinum, serinum, tyrosinum, acetas, citras, aminoacida, nitrogenia - infusionslösung - aminoacida: isoleucinum 5 g, leucinum 8.9 g, lysinum anhydricum 6.85 g ut lysini acetas et lysinum monohydricum, methioninum 4.4 g, phenylalaninum 4.7 g, threoninum 4.2 g, tryptophanum 1.6 g, valinum 6.2 g, argininum 11.5 g, histidinum 3 g, alaninum 10.5 g, glycinum 12 g, acidum asparticum 5.6 g, acidum glutamicum 7.2 g, prolinum 5.5 g, serinum 2.3 g, tyrosinum 0.4 g, mineralia: acetas 28 mmol/l, citras 1.0-2.0 mmol/l, alia: acetylcysteinum, acidum citricum monohydricum, aqua ad iniectabile q.s. ad solutionem pro 1000 ml, corresp., aminoacida 100 g/l, nitrogenia 15.8 g/l, corresp. 400 kj/l. - parenterale ernährung - synthetika